Recently, TRIB3 was reported to regulate the β-catenin pathway in colorectal cancer [15] and to suppress forkhead box protein O1 (FOXO1) phosphorylation in breast cancer [13] by helping to maintain cancer stem cells (CSCs). This evidence concerns the gene FOXO1 and colorectal cancer.